RadNetRDNT
About: RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Employees: 11,021
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
803% more call options, than puts
Call options by funds: $72.4M | Put options by funds: $8.01M
22% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 101
5.97% more ownership
Funds ownership: 86.27% [Q4 2024] → 92.24% (+5.97%) [Q1 2025]
7% less funds holding
Funds holding: 325 [Q4 2024] → 301 (-24) [Q1 2025]
24% less capital invested
Capital invested by funds: $4.46B [Q4 2024] → $3.4B (-$1.06B) [Q1 2025]
29% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 65
44% less funds holding in top 10
Funds holding in top 10: 9 [Q4 2024] → 5 (-4) [Q1 2025]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Truist Securities David Macdonald | 27%upside $74 | Buy Maintained | 11 Apr 2025 |
Barclays Andrew Mok | 3%upside $60 | Overweight Maintained | 24 Mar 2025 |
Raymond James John Ransom | 12%upside $65 | Strong Buy Upgraded | 5 Mar 2025 |
Financial journalist opinion
Based on 5 articles about RDNT published over the past 30 days









